Ivabradine Hydrochloride/Metoprolol Tartrate

盐酸伊伐布雷定/酒石酸美托洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIvabradine Hydrochloride/Metoprolol Tartrate
Drug Alias NameMetoprolol/Ivabradine酒石酸美托洛尔和盐酸伊伐布雷定Ivabradine/Metoprolol Tartrate美托洛尔/伊伐布雷定盐酸伊伐布雷定/美托洛尔 +[17] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsHyperpolarization-activated cyclic nucleotide-gated channel blockers
TargetsBeta adrenergic receptorsHyperpolarization-activated cyclic nucleotide-gated channel
Therapy Area/IndicationsAngina Pectoris
Global Approved IndicationsAngina Pectoris
Approved Indications in ChinaN/A
Original Approved Country/TerritoryNetherlands
Original Approved Date2015/01/01
Country/TerritoryNetherlands
CombinationsYes Metoprolol TartrateIvabradine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC07FX05
Related LinksN/A